These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36338570)

  • 1. Cytokine profiling in plasma distinguishes the histological inflammatory subtype of head and neck squamous cell carcinoma and a novel regulatory role of osteopontin.
    Ghita I; Piperi E; Atamas SP; Bentzen SM; Ord RA; Dyalram D; Lubek JE; Younis RH
    Front Oral Health; 2022; 3():993638. PubMed ID: 36338570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile.
    Younis RH; Ghita I; Elnaggar M; Chaisuparat R; Theofilou VI; Dyalram D; Ord RA; Davila E; Tallon LJ; Papadimitriou JC; Webb TJ; Bentzen SM; Lubek JE
    Front Immunol; 2021; 12():596646. PubMed ID: 33776991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.
    Derakhshandeh R; Sanadhya S; Lee Han K; Chen H; Goloubeva O; Webb TJ; Younis RH
    Oncotarget; 2018 Feb; 9(13):11126-11144. PubMed ID: 29541402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
    Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
    Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer.
    Maleš J; Mihalj H; Šestak A; Kralik K; Smolić M
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670031
    [No Abstract]   [Full Text] [Related]  

  • 7. Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma.
    Takada H; Ibaragi S; Eguchi T; Okui T; Obata K; Masui M; Morisawa A; Takabatake K; Kawai H; Yoshioka N; Hassan NMM; Shimo T; Hu GF; Nagatsuka H; Sasaki A
    Int J Oncol; 2017 Aug; 51(2):625-632. PubMed ID: 28656278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis].
    Zhao Hongchun ; Wang Yanfei ; Zheng Tihua ; Che Juan ; Cao Ruijuan ; Wang Xia
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1530-3. PubMed ID: 26647537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.
    Basile JR; Castilho RM; Williams VP; Gutkind JS
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9017-22. PubMed ID: 16754882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological pattern of tumor inflammation and stromal density correlate with patient demographics and immuno-oncologic transcriptional profile in oral squamous cell carcinoma.
    Theofilou VI; Ghita I; Elnaggar M; Chaisuparat R; Papadimitriou JC; Bentzen SM; Dyalram D; Lubek JE; Ord RA; Younis RH
    Front Oral Health; 2024; 5():1408072. PubMed ID: 38903181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
    Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
    Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
    Yoshida Y; Ogata A; Kang S; Ebina K; Shi K; Nojima S; Kimura T; Ito D; Morimoto K; Nishide M; Hosokawa T; Hirano T; Shima Y; Narazaki M; Tsuboi H; Saeki Y; Tomita T; Tanaka T; Kumanogoh A
    Arthritis Rheumatol; 2015 Jun; 67(6):1481-90. PubMed ID: 25707877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
    BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
    Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.